Equities

Yunkang Group Ltd

Yunkang Group Ltd

Actions
Health CareMedical Equipment and Services
  • Price (HKD)10.78
  • Today's Change-0.06 / -0.55%
  • Shares traded145.00k
  • 1 Year change-22.78%
  • Beta--
Data delayed at least 15 minutes, as of Jun 21 2024 02:57 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Yunkang Group Ltd is a China-based Company mainly engaged in the provision of diagnosis testing services. The Company operates three segments. Diagnosis Testing segment provides diagnosis testing to hospital and non-medical clients, mainly including routine diagnostic testing, routine pathological examination, infectious disease diagnostic testing, genetic disease diagnostic testing and early cancer detection. Hospital Management Business segment provides management services for the community clinics. Research & Development Institution segment is engaged in the research and development of testing kits. The Company primarily provides services for hospitals and other medical institutions, and commercial entities such as financial institutions and insurance companies.

  • Revenue in HKD (TTM)959.44m
  • Net income in HKD-110.05m
  • Incorporated2018
  • Employees1.51k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
C-Mer Eye Care Holdings Ltd1.92bn62.00m3.64bn3.27k58.721.9511.861.890.04940.04941.531.480.68128.9338.29587,828.903.060.92373.871.1232.1729.954.491.441.7516.840.15445.3311.0934.98383.427.8128.01--
China Resources Medical Holdings Com Ltd10.88bn277.32m4.94bn20.17k17.370.78984.890.45420.21940.21948.604.820.642324.506.63539,248.602.083.243.494.8018.8620.293.246.600.600523.910.247927.9527.9237.46-3.07-9.7753.23-10.66
Adicon Holdings Ltd3.55bn252.78m6.50bn5.71k26.693.5414.061.830.3350.3354.952.53------621,238.00--------43.49--7.95--1.786.600.3734---32.15---65.50------
Yunkang Group Ltd959.44m-110.05m6.73bn1.51k--2.96--7.02-0.1848-0.18481.573.660.188919.070.4519635,387.40-2.166.70-3.8811.1936.5442.42-11.4310.991.75--0.39619.89-76.278.38-127.10--33.22--
Jiangxi Rimag Group Co Ltd-100.00bn-100.00bn7.10bn1.01k------------------------------------------------18.42--12,101.92------
Jinxin Fertility Group Ltd3.00bn370.99m8.44bn3.27k23.200.766612.382.810.13190.13191.103.990.185125.8221.31917,028.302.302.642.723.0142.1541.7612.4414.900.757511.580.214741.5217.9524.78184.6015.6552.59--
Gushengtang Holdings Ltd2.50bn271.42m9.90bn2.66k36.674.0224.663.961.101.1010.2410.060.774812.5917.25940,352.608.43-4.8710.69-9.9130.1337.0910.89-6.672.38--0.1385--43.0126.1839.45--26.99--
Data as of Jun 21 2024. Currency figures normalised to Yunkang Group Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

0.01%Per cent of shares held by top holders
HolderShares% Held
SSgA Funds Management, Inc.as of 06 Jun 202480.50k0.01%
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.